Comparison of Effects of Sugammadex And Neostigmine on Postoperative Neuromuscular Blockade Recovery in Patients with Interstitial Lung Diseases Undergoing Transbronchial Cryobiopsy: A Randomized Trial

Overview

Journal Med Sci Monit

Specialties General Medicine
Pathology

Date 2024 May 1

PMID 38689479

Authors

Liya Lu

Xiaobo Chen

Shiyue Li

Yanyi Cen

Affiliations

Soon will be listed here.

Abstract

BACKGROUND While many studies have been conducted on sugammadex sodium and neostigmine in patients undergoing general anesthesia, few have explored their effects in patients with interstitial lung diseases (ILDs). MATERIAL AND METHODS Sixty-three patients who underwent transbronchial cryobiopsy under general anesthesia were enrolled in a prospective randomized study. The patients were randomly divided into 2 groups: neostigmine combined with atropine group (group C, n=32) and sugammadex group (group S, n=31). Induction and maintenance of anesthesia were the same in both groups. Patients received rocuronium during anesthesia. At the end of the procedure, when the T2 of the train-of-four stimulation technique (TOF) monitoring appeared, neostigmine 0.04 mg/kg combined with atropine 0.02 mg/kg was injected intravenously in group C, and sodium sugammadex 2 mg/kg was injected intravenously in group S. Time from administration of muscle relaxant antagonist to recovery of TOF ratio (TOFr) to 0.9 and extubation time were recorded. The residual rate of neuromuscular blockade at 1, 3, 5, 7, and 10 min after extubation was calculated. RESULTS Compared to group C, group S had a significantly shorter recovery time of TOFr to 0.9 (4.0[2.0] min vs 14.0[11.0] min, P<0.001) and extubation time (4.0[3.0] min vs 11.0[7.0] min, P<0.001). The residual rate of neuromuscular blockade was remarkably lower in group S than in group C at 3, 5, and 7 min after extubation (3.2% vs 31%, 0% vs 25%, 0% vs 6%, P<0.05). CONCLUSIONS Sugammadex is more effective than neostigmine in reversing the muscle-relaxant effect of rocuronium bromide in patients with ILDs.

References

Unterbuchner C . Neuromuscular Block and Blocking Agents in 2018. Turk J Anaesthesiol Reanim. 2018; 46(2):75-80. PMC: 5937467. DOI: 10.5152/TJAR.2018.200318. View

Broens S, Boon M, Martini C, Niesters M, van Velzen M, Aarts L . Reversal of Partial Neuromuscular Block and the Ventilatory Response to Hypoxia: A Randomized Controlled Trial in Healthy Volunteers. Anesthesiology. 2019; 131(3):467-476. DOI: 10.1097/ALN.0000000000002711. View

Colomina M, Ripolles-Melchor J, Guilabert P, Jover J, Basora M, Cassinello C . Observational study on fluid therapy management in surgical adult patients. BMC Anesthesiol. 2021; 21(1):316. PMC: 8667365. DOI: 10.1186/s12871-021-01518-z. View

Nemes R, Fulesdi B, Pongracz A, Asztalos L, Szabo-Maak Z, Lengyel S . Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial. Eur J Anaesthesiol. 2016; 34(9):609-616. DOI: 10.1097/EJA.0000000000000585. View

Hetzel J, Maldonado F, Ravaglia C, Wells A, Colby T, Tomassetti S . Transbronchial Cryobiopsies for the Diagnosis of Diffuse Parenchymal Lung Diseases: Expert Statement from the Cryobiopsy Working Group on Safety and Utility and a Call for Standardization of the Procedure. Respiration. 2018; 95(3):188-200. DOI: 10.1159/000484055. View

Sabate S, Mazo V, Canet J . Predicting postoperative pulmonary complications: implications for outcomes and costs. Curr Opin Anaesthesiol. 2014; 27(2):201-9. DOI: 10.1097/ACO.0000000000000045. View

Togioka B, Yanez D, Aziz M, Higgins J, Tekkali P, Treggiari M . Randomised controlled trial of sugammadex or neostigmine for reversal of neuromuscular block on the incidence of pulmonary complications in older adults undergoing prolonged surgery. Br J Anaesth. 2020; 124(5):553-561. DOI: 10.1016/j.bja.2020.01.016. View

Abad-Gurumeta A, Ripolles-Melchor J, Casans-Frances R, Espinosa A, Martinez-Hurtado E, Fernandez-Perez C . A systematic review of sugammadex vs neostigmine for reversal of neuromuscular blockade. Anaesthesia. 2015; 70(12):1441-52. DOI: 10.1111/anae.13277. View

Kheterpal S, Vaughn M, Dubovoy T, Shah N, Bash L, Colquhoun D . Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis. Anesthesiology. 2020; 132(6):1371-1381. PMC: 7864000. DOI: 10.1097/ALN.0000000000003256. View

10.

Carron M, Zarantonello F, Tellaroli P, Ori C . Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials. J Clin Anesth. 2016; 35:1-12. DOI: 10.1016/j.jclinane.2016.06.018. View

11.

Li G, Freundlich R, Gupta R, Hayhurst C, Le C, Martin B . Postoperative Pulmonary Complications' Association with Sugammadex versus Neostigmine: A Retrospective Registry Analysis. Anesthesiology. 2021; 134(6):862-873. PMC: 8114582. DOI: 10.1097/ALN.0000000000003735. View

12.

Cammu G, Schepens T, De Neve N, Wildemeersch D, Foubert L, Jorens P . Diaphragmatic and intercostal electromyographic activity during neostigmine, sugammadex and neostigmine-sugammadex-enhanced recovery after neuromuscular blockade: A randomised controlled volunteer study. Eur J Anaesthesiol. 2016; 34(1):8-15. DOI: 10.1097/EJA.0000000000000543. View

13.

Cho S, Kim J, Cho C, Sung T . The Effect of Neuromuscular Blockade Reversal Agents on Postoperative Pulmonary Complications in Patients undergoing Femur Fracture Repair Surgery: A Retrospective Observational Study. Ann Geriatr Med Res. 2023; 27(3):212-219. PMC: 10556711. DOI: 10.4235/agmr.23.0060. View

14.

Ledowski T, Falke L, Johnston F, Gillies E, Greenaway M, De Mel A . Retrospective investigation of postoperative outcome after reversal of residual neuromuscular blockade: sugammadex, neostigmine or no reversal. Eur J Anaesthesiol. 2013; 31(8):423-9. DOI: 10.1097/EJA.0000000000000010. View

15.

Ding X, Zhu X, Zhao C, Chen D, Wang Y, Liang H . Use of sugammadex is associated with reduced incidence and severity of postoperative nausea and vomiting in adult patients with obesity undergoing laparoscopic bariatric surgery: a post-hoc analysis. BMC Anesthesiol. 2023; 23(1):163. PMC: 10184386. DOI: 10.1186/s12871-023-02123-y. View

16.

Kumar G, Pramod Nair A, Srinivasa Murthy H, Jalaja K, Ramachandra K, Parameshwara G . Residual neuromuscular blockade affects postoperative pulmonary function. Anesthesiology. 2012; 117(6):1234-44. DOI: 10.1097/ALN.0b013e3182715b80. View

17.

Ji Y, Yuan H, Chen Y, Zhang X, Wu F, Tang W . Sugammadex Is Associated With Reduced Pulmonary Complications in Patients With Respiratory Dysfunction. J Surg Res. 2023; 290:133-140. DOI: 10.1016/j.jss.2023.04.023. View

18.

Blobner M, Hunter J, Meistelman C, Hoeft A, Hollmann M, Kirmeier E . Use of a train-of-four ratio of 0.95 versus 0.9 for tracheal extubation: an exploratory analysis of POPULAR data. Br J Anaesth. 2019; 124(1):63-72. DOI: 10.1016/j.bja.2019.08.023. View

19.

Ravaglia C, Bonifazi M, Wells A, Tomassetti S, Gurioli C, Piciucchi S . Safety and Diagnostic Yield of Transbronchial Lung Cryobiopsy in Diffuse Parenchymal Lung Diseases: A Comparative Study versus Video-Assisted Thoracoscopic Lung Biopsy and a Systematic Review of the Literature. Respiration. 2016; 91(3):215-27. DOI: 10.1159/000444089. View

20.

Hristovska A, Duch P, Allingstrup M, Afshari A . The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. A Cochrane systematic review with meta-analysis and trial sequential analysis. Anaesthesia. 2017; 73(5):631-641. DOI: 10.1111/anae.14160. View